求助”Human Vaccines &Immunotherapeutics“期刊的参考文献格式

swhqhjc

引文为数字上标，无括号
参考文献题录信息如下：
References
1. Bianchini G, Balko JM, Mayer IA, Sanders ME, Gianni L. Triplenegative breast cancer: challenges and opportunities ofa heterogeneous disease. Nat Rev Clin Oncol. 2016;13(11):674–690. doi:10.1038/nrclinonc.2016.66 .
2. Hodi FS, O’Day SJ, McDermott DF, Weber RW, Sosman JA,Haanen JB, Gonzalez R, Robert C, Schadendorf D, Hassel JC,et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med. 2010;363:711–723. doi:10.1056/NEJMoa1003466 .
3. Shi Y, Wang Y, Dong H, Niu K, Zhang W, Feng K, Yang R,Zhang Y. Crosstalk of ferroptosis regulators and tumor immunityin pancreatic adenocarcinoma: novel perspective to mRNA vaccines and personalized immunotherapy. Apoptosis. 2023;28(9–10):1423–1435. doi:10.1007/s10495-023-01868-8 .
4. Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologiesfor cancer immunotherapy. Nat Rev Drug Discov. 2019;18(3):175–196. doi:10.1038/s41573-018-0006-z .
5. Yap TA, Parkes EE, Peng W, Moyers JT, Curran MA, Tawbi HA.Development of immunotherapy combination strategies in cancer.Cancer Discov. 2021;11(6):1368–1397. doi:10.1158/2159-8290.CD-20-1209 .
6. Zhang Y, Zhang Z. The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltratingimmune cells and their therapeutic implications. Cell MolImmunol. 2020;17(8):807–821. doi:10.1038/s41423-020-0488-6 .
7. Baxevanis CN, Perez SA, Papamichail M. Cancer immunotherapy.Crit Rev Clin Lab Sci. 2009;46(4):167–189. doi:10.1080/10408360902937809 .

aegeansupport

Human Vaccines & Immunotherapeutics